Deciphering the Mysterious Relationship between the Cross-Pathogenetic Mechanisms of Neurodegenerative and Oncological Diseases

被引:3
作者
Aleksandrova, Yulia [1 ]
Neganova, Margarita [1 ,2 ]
机构
[1] Russian Acad Sci, Inst Physiol Act Cpds, Fed Res Ctr Problems Chem Phys & Med Chem, Chernogolovka 142432, Russia
[2] Russian Acad Sci, Arbuzov Inst Organ & Phys Chem, FRC Kazan Sci Ctr, Kazan 420088, Russia
关键词
neurodegenerative diseases; Alzheimer's disease; cancer; molecular mechanisms of pathogenesis; oxidative stress; epigenetics; metabolism; drugs; NF-KAPPA-B; HISTONE DEACETYLASE 3; BREAST-CANCER CELLS; SUBEROYLANILIDE HYDROXAMIC ACID; CARBONIC-ANHYDRASE ACTIVITIES; INDUCED COGNITIVE IMPAIRMENT; CYTOCHROME-C-OXIDASE; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; GASTRIC-CANCER;
D O I
10.3390/ijms241914766
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The relationship between oncological pathologies and neurodegenerative disorders is extremely complex and is a topic of concern among a growing number of researchers around the world. In recent years, convincing scientific evidence has accumulated that indicates the contribution of a number of etiological factors and pathophysiological processes to the pathogenesis of these two fundamentally different diseases, thus demonstrating an intriguing relationship between oncology and neurodegeneration. In this review, we establish the general links between three intersecting aspects of oncological pathologies and neurodegenerative disorders, i.e., oxidative stress, epigenetic dysregulation, and metabolic dysfunction, examining each process in detail to establish an unusual epidemiological relationship. We also focus on reviewing the current trends in the research and the clinical application of the most promising chemical structures and therapeutic platforms that have a modulating effect on the above processes. Thus, our comprehensive analysis of the set of molecular determinants that have obvious cross-functional pathways in the pathogenesis of oncological and neurodegenerative diseases can help in the creation of advanced diagnostic tools and in the development of innovative pharmacological strategies.
引用
收藏
页数:56
相关论文
共 576 条
[71]  
Cobanoglu U, 2010, ASIAN PAC J CANCER P, V11, P1377
[72]   Targeting HDAC2-Mediated Immune Regulation to Overcome Therapeutic Resistance in Mutant Colorectal Cancer [J].
Conte, Mariarosaria ;
Di Mauro, Annabella ;
Capasso, Lucia ;
Montella, Liliana ;
De Simone, Mariacarla ;
Nebbioso, Angela ;
Altucci, Lucia .
CANCERS, 2023, 15 (07)
[73]   Loss of HDAC6, a novel CHIP substrate, alleviates abnormal tau accumulation [J].
Cook, Casey ;
Gendron, Tania F. ;
Scheffel, Kristyn ;
Carlomagno, Yari ;
Dunmore, Judy ;
DeTure, Michael ;
Petrucelli, Leonard .
HUMAN MOLECULAR GENETICS, 2012, 21 (13) :2936-2945
[74]   The role of glutathione reductase and related enzymes on cellular redox homoeostasis network [J].
Couto, Narciso ;
Wood, Jennifer ;
Barber, Jill .
FREE RADICAL BIOLOGY AND MEDICINE, 2016, 95 :27-42
[75]   The dual role of tumor necrosis factor-alpha (TNF-α) in breast cancer: molecular insights and therapeutic approaches [J].
Cruceriu, Daniel ;
Baldasici, Oana ;
Balacescu, Ovidiu ;
Berindan-Neagoe, Ioana .
CELLULAR ONCOLOGY, 2020, 43 (01) :1-18
[76]   Concomitant histone deacetylase and phosphodiesterase 5 inhibition synergistically prevents the disruption in synaptic plasticity and it reverses cognitive impairment in a mouse model of Alzheimer's disease [J].
Cuadrado-Tejedor, M. ;
Garcia-Barroso, C. ;
Sanzhez-Arias, J. ;
Mederos, S. ;
Rabal, O. ;
Ugarte, A. ;
Franco, R. ;
Pascual-Lucas, M. ;
Segura, V. ;
Perea, G. ;
Oyarzabal, J. ;
Garcia-Osta, A. .
CLINICAL EPIGENETICS, 2015, 7
[77]   Modulating ROS to overcome multidrug resistance in cancer [J].
Cui, Qingbin ;
Wang, Jing-Quan ;
Assaraf, Yehuda G. ;
Ren, Liang ;
Gupta, Pranav ;
Wei, Liuya ;
Ashby, Charles R., Jr. ;
Yang, Dong-Hua ;
Chen, Zhe-Sheng .
DRUG RESISTANCE UPDATES, 2018, 41 :1-25
[78]   Parthenolide generates reactive oxygen species and autophagy in MDA-MB231 cells. A soluble parthenolide analogue inhibits tumour growth and metastasis in a xenograft model of breast cancer [J].
D'Anneo, A. ;
Carlisi, D. ;
Lauricella, M. ;
Puleio, R. ;
Martinez, R. ;
Di Bella, S. ;
Di Marco, P. ;
Emanuele, S. ;
Di Fiore, R. ;
Guercio, A. ;
Vento, R. ;
Tesoriere, G. .
CELL DEATH & DISEASE, 2013, 4 :e891-e891
[79]   Role of Nrf2 in Synaptic Plasticity and Memory in Alzheimer's Disease [J].
Davies, Don A. ;
Adlimoghaddam, Aida ;
Albensi, Benedict C. .
CELLS, 2021, 10 (08)
[80]   NRF2 and the Hallmarks of Cancer [J].
de la Vega, Montserrat Rojo ;
Chapman, Eli ;
Zhang, Donna D. .
CANCER CELL, 2018, 34 (01) :21-43